VRTX
VERTEX PHARMACEUTICALS INC / MA
VERTEX PHARMACEUTICALS INC / MA (VRTX) has 9 SEC Form 4 filings (34 transaction rows) in the rolling window, disclosed by 6 distinct insiders. Most recent filing: Jul 7, 2026.
The most active filer is EVP and CMO Bozic Carmen with 3 filings. Insiders have net sold $24.3M over the trailing 6 months.
- Industry:Biotechnology
- CEO:Reshma Kewalramani
- Employees:6,100
- HQ:Boston, MA, US
- IPO:1991-07-24
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$53.0M
reported sales (SEC code S)
Unique Insiders
6
in the rolling window
Market Cap
$123.4B
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
McKechnie DuncanFirst filing | EVP, Chief Commercial Officer | Sale | 1,541 | $800K | Jul 7 | SEC ↗ |
Tatsis OuraniaFirst filing | EVP, Chief Reg. & Quality Off. | Sale | 1,500 | $787K | Jul 7 | SEC ↗ |
Liu JoyFirst filing | EVP and Chief Legal Officer | Sale | 828 | $416K | Jul 6 | SEC ↗ |
| EVP and CMO | Sale | 596 | $288K | Jun 30 | SEC ↗ | |
| EVP and CMO | Sale | 1,020 | $471K | Jun 23 | SEC ↗ | |
Bozic CarmenFirst filing | EVP and CMO | Sale | 4,062 | $1.8M | Jun 17 | SEC ↗ |
Kewalramani ReshmaFirst filing | CEO & President | Sale | 40,000 | $19.7M | Mar 3 | SEC ↗ |
LEIDEN JEFFREY MFirst filing | Executive Chairman | Sale | 63,781 | $28.7M | Dec 5 | SEC ↗ |
Congress trading VRTX
See timeline →- DRep. Ro KhannaPurchase$1,001 - $15,0002026-04-13
STOCK Act disclosures are filed up to 45 days after the trade. Amount is a disclosed range, not an exact figure.
Related companies
VERTEX PHARMACEUTICALS INC / MA is in the Healthcare sector.